However, a case of severe OHSS was reported in a woman with breast cancer and PCOS treated with letrozole and GnRH agonist, suggesting that these treatments do not eliminate the risk of OHSS [52]. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.